Hyponatremia and mortality in patients undergoing maintenance hemodialysis: Systematic review and meta‐analysis
Seminars in Dialysis · 2023-07 · 36 (4) · 303-315
DOI: 10.1111/sdi.13140 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Seminars in Dialysis, online erschienen am 16.03.2023. Verfasst von Takamasa Miyauchi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Daini Hattori Clinic, Tokyo, Japan. Hauptthemen laut MEDLINE: Hyponatremia, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Introduction
This systematic review and meta‐analysis examined the relationship between hyponatremia and worse outcomes in patients undergoing maintenance hemodialysis.
Methods
The MEDLINE, EMBASE, CENTRAL, and Web of Science databases were used to search for relevant articles. The target population was patients on maintenance hemodialysis (those undergoing hemodialysis for ≥60 days). The defined outcomes were death, cardiovascular disease, cognitive decline, and falls. Meta‐analysis was performed with a random‐effects model of pairwise comparisons of normonatremia and hyponatremia defined for each study, 1‐mmol/L increment of sodium analysis, and dose–response analysis using the sodium concentration defined for each study. This study was registered with PROSPERO (registration number CRD42018087667).
Results
Thirteen articles were included. The pairwise analysis revealed that the hazard ratio for all‐cause mortality was 1.45 (95% confidence interval, 1.31–1.61). The analysis of 1‐mmol/L increment of sodium included six studies with a hazard ratio for all‐cause mortality of 0.94 (95% confidence interval, 0.91–0.97) for each 1‐mmol/L increase in the serum sodium concentration. In the dose–response analysis, assuming a linear relationship, a sodium increment of 1 mmol/L revealed a hazard ratio for all‐cause mortality of 0.97 (95% confidence interval, 0.96–0.98). Other outcomes could not be integrated.
Conclusions
Hyponatremia is associated with all‐cause mortality in patients undergoing maintenance hemodialysis. Healthcare providers should pay special attention to even the slightest indication of hyponatremia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Daini Hattori Clinic, Tokyo, Japan.
- Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
- Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
- Showa University Research Administration Center (SURAC), Tokyo, Japan.
ORCID-Profile: Hiroki Nishiwaki, Masahiko Yazawa
Zitieren
APA
Miyauchi, T., Nishiwaki, H., Mizukami, A., & Yazawa, M. (2023). Hyponatremia and mortality in patients undergoing maintenance hemodialysis: Systematic review and meta‐analysis. Seminars in Dialysis, 36(4), 303-315. https://doi.org/10.1111/sdi.13140
Vancouver
Miyauchi T, Nishiwaki H, Mizukami A, Yazawa M. Hyponatremia and mortality in patients undergoing maintenance hemodialysis: Systematic review and meta‐analysis. Seminars in Dialysis. 2023;36(4):303-315. doi:10.1111/sdi.13140
BibTeX
@article{Miyauchi2023,
author = {Miyauchi, Takamasa and Nishiwaki, Hiroki and Mizukami, Aya and Yazawa, Masahiko},
title = {Hyponatremia and mortality in patients undergoing maintenance hemodialysis: Systematic review and meta‐analysis},
journal = {Seminars in Dialysis},
year = {2023},
volume = {36},
number = {4},
pages = {303--315},
doi = {10.1111/sdi.13140}
}
EUVIMED